AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
Selling, General & Administrative
AxoGen Inc
Selling, General & Administrative Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AxoGen Inc
NASDAQ:AXGN
|
Selling, General & Administrative
-$117.5m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-19%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Selling, General & Administrative
-$5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Selling, General & Administrative
-$6B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-8%
|
|
|
Stryker Corp
NYSE:SYK
|
Selling, General & Administrative
-$7.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Selling, General & Administrative
-$11.7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Selling, General & Administrative
-$2.1B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
|
AxoGen Inc
Glance View
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.
See Also
What is AxoGen Inc's Selling, General & Administrative?
Selling, General & Administrative
-117.5m
USD
Based on the financial report for Dec 31, 2024, AxoGen Inc's Selling, General & Administrative amounts to -117.5m USD.
What is AxoGen Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-19%
Over the last year, the Selling, General & Administrative growth was 0%. The average annual Selling, General & Administrative growth rates for AxoGen Inc have been -4% over the past three years , -3% over the past five years , and -19% over the past ten years .
You don't have any saved screeners yet